✦ LIBER ✦

C4. Cost-effectiveness trends of HMG-CoA reductase inhibitor therapy in a managed-care population

✍ Scribed by A. Petitta; R.E. Ward; J.V. Anandan; S.J. Beis; A.M. Johnson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV35: COST EFFECTIVENESS ANALYSIS OF HM

✍ EA MacLean; CM Moffitt 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

PDB10: ECONOMIC OUTCOMES OF HMG CoA REDU

✍ TJ White; M Juzba; DM Berenbeim; AM Gilderman; JC Salas 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

PCV20 A COST-EFFECTIVENESS ANALYSIS OF S

✍ MF Bullano; VJ Willey; MJ Cziraky; L Graham; JC Corbelli 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

PCV22: COST-EFFECTIVENESS OF HMG-CoA RED

✍ LB Lazebnik; MJ Kadiskaya 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

A Comparison of Continuous Combined Horm

✍ Serdar Ozsener; Dr. Fatih Sendag; Tayfun Koc; Mustafa Cosan Terek; Kemal Oztekin 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 501 KB

Effect of a HMG-CoA reductase inhibitor

✍ Hiroaki Ohta; Shigeyuki Komukai; Itaru Sugimoto; Takahisa Fuyuki; Kazuya Makita; 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 110 KB